The evidence in the case included internal documents from several decades that showed the jury that Johnson & Johnson knew about the risks of talc and ovarian cancer. A Los Angeles jury on Monday ordered Johnson & Johnson to pay a …
Johnson & Johnson (J&J) was ordered by a Los Angeles jury to pay $417 million to a 62-year-old woman who blamed her ovarian cancer on the company's talc, in the first California trial over the product. The jury found the parent company …
Johnson & Johnson was ordered by a Missouri jury to pay $72 million in damages to the family of a woman whose death from ovarian cancer was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several …
These are external links and will open in a new window Johnson & Johnson has been ordered to pay $417m (£323.4m) to a woman who says she developed ovarian cancer after using products such as baby powder. The California jury's …
BBC2mon
A St. Louis jury has awarded a Virginia woman a record-setting $110.5 million in the latest lawsuit alleging that using Johnson & Johnson’s baby powder caused cancer. The jury ruling Thursday night for 62-year-old Lois Slemp of Wise, …
TRENTON, New Jersey — Two chemicals considered harmful to babies remain in Johnson & Johnson's baby shampoo sold in the U.S. and some other countries, even though the company already makes versions without them, according …
Johnson & Johnson and its drugs unit will pay $2.2 billion to the U.S. government and 45 states to end civil and criminal investigations into unethical drug marketing practices. Four whistleblower lawsuits exposed kickbacks to pharmacists …
CBC4y
In today's episode, we offer up some insights into the risks and rewards associated with owning pharmaceutical dividend darlings Johnson & Johnson, AbbVie, and Pfizer.
Calamos Wealth Management Llc acquired 11,869 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The …